Seven Eight Capital, LP Amgen Inc Transaction History

Seven Eight Capital, LP

$918 Million
Q2 2024

A detailed history of Seven Eight Capital, LP transactions in Amgen Inc stock. As of the latest transaction made, Seven Eight Capital, LP holds 2,706 shares of AMGN stock, worth $855,096. This represents 0.09% of its overall portfolio holdings.

Number of Shares

2,706

Holding current value

$855,096

% of portfolio

0.09%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$262.75 - $319.31 $711,001 - $864,052	2,706 New	2,706 $845,000
Q2 2020 Aug 06, 2020	SELL	$197.81 - $242.74 $1.31 Million - $1.6 Million	-6,600 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $1.2 Million - $1.6 Million	6,600 New	6,600 $1.34 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $5.26 Million - $6.76 Million	-27,813 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $7.9 Million - $9.47 Million	-45,400 Reduced 62.01%	27,813 $5.38 Million
Q2 2019 Aug 12, 2019	BUY	$166.7 - $195.41 $3.44 Million - $4.03 Million	20,613 Added 39.19%	73,213 $13.5 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $9.51 Million - $10.7 Million	52,600 New	52,600 $9.99 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $2.21 Million - $2.58 Million	-12,400 Closed	0 $0
Q3 2018 Oct 18, 2018	BUY	$185.29 - $208.89 $352,051 - $396,891	1,900 Added 18.1%	12,400 $2.57 Million
Q2 2018 Aug 07, 2018	SELL	$166.05 - $186.51 $298,890 - $335,718	-1,800 Reduced 14.63%	10,500 $1.94 Million
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $2.22 Million - $2.59 Million	-13,100 Reduced 51.57%	12,300 $2.1 Million
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $4.29 Million - $4.79 Million	25,400 New	25,400 $4.42 Million
Q3 2017 Oct 16, 2017	SELL	$167.29 - $191.0 $635,702 - $725,800	-3,800 Closed	0 $0
Q2 2017 Aug 10, 2017	BUY	N/A	3,800	3,800 $654,000

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.

Account

Seven Eight Capital, LP Amgen Inc Transaction History